Stay updated on Timing of Pembrolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Timing of Pembrolizumab in NSCLC Clinical Trial page.

Latest updates to the Timing of Pembrolizumab in NSCLC Clinical Trial page
- CheckyesterdayChange DetectedNew study-record versions dated September 26 and September 30, 2026, are listed, with updates to study status and contacts/locations. The September 21 date no longer appears in the history.SummaryDifference0.1%

- Check8 days agoChange DetectedThe history now includes new submissions dated 2026-09-18 and 2026-09-21, adding Study Status and Study Identification sections to the record. An entry dated 2026-08-28 was removed from the history, indicating an adjustment to the version history of the study.SummaryDifference0.0%

- Check15 days agoChange DetectedThe Record History page now shows Revision: v3.7.0, replacing the previous v3.6.6, indicating a refreshed version of the study history.SummaryDifference0.0%

- Check36 days agoChange DetectedThe history now includes a new version entry (2026-08-28, revision v3.6.6) that updates the Contacts/Locations and Study Status sections, and the prior revision (v3.6.5) was removed.SummaryDifference0.0%

- Check51 days agoChange DetectedOn 2026-08-04, the version history adds Contacts/Locations and Study Status entries and updates the record to revision v3.6.5.SummaryDifference0.0%

- Check65 days agoChange DetectedCore study record details for Contacts/Locations and Study Status were added to the history, along with an item labeled 690, and the entry from 2026-07-02 was deleted.SummaryDifference0.0%

Stay in the know with updates to Timing of Pembrolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Timing of Pembrolizumab in NSCLC Clinical Trial page.